Evidence map›Paper›PMID 18990963›Full record

ReviewInternational journal of chronic obstructive pulmonary disease2008

Identifying targets for COPD treatment through gene expression analyses.

Zhi-Hua Chen, Hong Pyo Kim, Stefan W Ryter, Augustine M K Choi

Abstract readReview
In one paragraph

Review in International journal of chronic obstructive pulmonary disease, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Mendelian causes of early-onset emphysema: a review of the current literature.European respiratory review : an official journal of the European Respiratory Society · 2025
    Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Personalized Analysis by Validation of Monte Carlo for Application of Pathways in Cardioembolic Stroke.Medical science monitor : international medical journal of experimental and clinical research · 2017
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Comprehensive analysis of gene-expression profile in chronic obstructive pulmonary disease.International journal of chronic obstructive pulmonary disease · 2015
    Article
  18. Integrative genomics of chronic obstructive pulmonary disease.Biochemical and biophysical research communications · 2014
    Review
  19. Article
  20. RNAi Therapeutic Platforms for Lung Diseases.Pharmaceuticals (Basel, Switzerland) · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Zhi-Hua ChenDivision of Pulmonary, Allergy and Critical Care Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
Hong Pyo Kim
Stefan W Ryter
Augustine M K Choi

Funding

NITRIC OXIDE AND METALLOTIONEIMP01HL070807 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KAGAN, VALERIAN E · 2003 to 2007
$8.1M
The Role of HEME Oxygenase in Hyperoxic Lung InjuryR01HL055330 · NHLBI · YALE UNIVERSITY · PI CHOI, AUGUSTINE M, CHOI, MARY E · 1998 to 2021
$6.6M
HEME OXYGENASE 1--LUNG VASCULAR CELL HYPOXIC RESPONSER01HL060234 · NHLBI · YALE UNIVERSITY · PI CHOI, AUGUSTINE M, CHOI, MARY E · 1999 to 2017
$5.8M
Heme oxygenase-1: Regulation and Function in CaveolaeR01HL079904 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI CHOI, MARY E · 2005 to 2014
$2.9M
NHLBI NIH HHS P01 HL070807NHLBI NIH HHS P01-HL70807NHLBI NIH HHS R01 HL055330NHLBI NIH HHS R01 HL060234NHLBI NIH HHS R01 HL079904NHLBI NIH HHS R01-HL079904NHLBI NIH HHS R01-HL55330NHLBI NIH HHS R01-HL60234
6 · The paper itself

Abstract

Despite the status of chronic obstructive pulmonary disease (COPD) as a major global health problem, no currently available therapies can limit COPD progression. Therefore, an urgent need exists for the development of new and effective treatments for COPD. An improved understanding in the molecular pathogenesis of COPD can potentially identify molecular targets to facilitate the development of new therapeutic modalities. Among the best approaches for understanding the molecular basis of COPD include gene expression profiling techniques, such as serial analysis of gene expression or microarrays. Using these methods, recent studies have mapped comparative gene expression profiles of lung tissues from patients with different stages of COPD relative to healthy smokers or non-smokers. Such studies have revealed a number of differentially-regulated genes associated with COPD progression, which include genes involved in the regulation of inflammation, extracellular matrix, cytokines, chemokines, apoptosis, and stress responses. These studies have shed new light on the molecular mechanisms of COPD, and suggest novel targets for clinical treatments.

Indexed as

ApoptosisCell Adhesion MoleculesCell ProliferationDisease ProgressionEarly Growth Response Protein 1Gene Expression ProfilingHeme Oxygenase-1Histone DeacetylasesHumansMatrix Metalloproteinase InhibitorsMatrix MetalloproteinasesNF-kappa BOligonucleotide Array Sequence AnalysisOxidative Stressp38 Mitogen-Activated Protein KinasesPulmonary Disease, Chronic ObstructiveCell Adhesion MoleculesEarly Growth Response Protein 1EGR1 protein, humanHeme Oxygenase-1Histone DeacetylasesMatrix Metalloproteinase InhibitorsMatrix MetalloproteinasesNF-kappa Bp38 Mitogen-Activated Protein KinasesReceptors, Chemokine

Identifiers

PMID18990963
PMCPMC2629979

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.